Back to search
FDAFDA · Food and drugs·Recall number Z-1945-2024

IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

Published June 12, 2024 · Recall initiated: May 10, 2024

Summary

FDA records medical device Class II recall Z-1945-2024, published June 12, 2024 and initiated May 10, 2024. Recalling firm: Ion Beam Applications S.A.; Status: Ongoing; Reported quantity: 2 units; Lot: UDI: SAT140: (01)05404013814015(11)190507(21)SAT140 SAT136: (01)05404013801138(11)201105(21)SAT136 Serial Numbers: SAT136, SAT140 PTS-11 versions from PTS-11.1 and PTS-12 versions, with C230 accelerator. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ion Beam Applications S.A.
Distributor
Worldwide - US Nationwide distribution in the state of Virginia and the country of India.
Lot
UDI: SAT140: (01)05404013814015(11)190507(21)SAT140 SAT136: (01)05404013801138(11)201105(21)SAT136 Serial Numbers: SAT136, SAT140 PTS-11 versions from PTS-11.1 and PTS-12 versions, with C230 accelerator
Risk classification
Class II
Area (FDA)
device
Country
Belgium

Related recalls

Questions about this recall

Was IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. recalled?

Yes. FDA published recall Z-1945-2024 on June 12, 2024. Reported hazard: Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances

What should I do if I have this product?

Voluntary: Firm initiated · Letter